#Immuno Oncology Assays Market Scope | Explore Tumblr Posts and Blogs

marketresearch-articles · 3 years

Text

Immunoassay Reagents and Devices Market Size, Exclusive Research Report by The Insight Partners

Immunoassay Reagents and Devices Market is grow at a CAGR 4.9% in the forecast 2021 to 2028.

Immunoassay Reagents and Devices Market Scope and Size

· On the basis of product, the immunoassay reagents and devices market is segmented into reagents & kits and analyzers. In 2021, reagents & kits segment is dominating due to its higher usage in drug development as well as in disease detection.

· On the basis of platform, the immunoassay reagents and devices market is segmented into chemiluminescence immunoassays, fluorescence immunoassays, enzyme immunoassay, radioimmunoassays and others. In 2021, enzyme immunoassay segment is dominating the market because of its advantages such as ease in performing test, accurate result and many others.

· On the basis of technique, the immunoassay reagents and devices market is segmented into enzyme-linked immunosorbent assays, rapid tests, enzyme-linked immunospot, western blotting, immuno-PCR and other techniques. In 2021, enzyme-linked immunosorbent assays segment is dominating because it is highly sensitive, simple to perform, offer accurate result for any disease detection or in any drug development.

· On the basis of specimen type, the immunoassay reagents and devices market is segmented into saliva, urine, blood and others. In 2021, blood segment is dominating the market because antigen can be easily detected from the blood.

· On the basis of application, the immunoassay reagents and devices market is segmented into infectious diseases, oncology and endocrinology, bone & mineral disorders, cardiology, hematology & blood screening, autoimmune disorders, toxicology, neonatal screening and other applications. In 2021, oncology and endocrinology segment is dominating because of high incidence rate worldwide which can be detected easily with the use of immunoassays.

Get the sample copy of Report https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-immunoassay-reagents-and-devices-market

Global Immunoassay Reagents and Devices Market Country Level Analysis

Global immunoassay reagents and devices market is analyzed and market size information is provided by the country, product, platform, technique, specimen type, application and end user as referenced above.

The countries covered in the global immunoassay reagents and devices market report are the U.S., Canada, Mexico, Germany, Italy, France, U.K., Spain, Russia, Netherlands, Switzerland, Belgium, Turkey, rest of Europe, China, Japan, India, Australia, Singapore, Indonesia, Thailand, South Korea, Malaysia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, Saudi Arabia, South Africa, Egypt, UAE, Israel and rest of Middle East and Africa.

Immunoassay Reagents and Devices Market research report indicates that the global Immunoassay Reagents and Devices Market is expected to surge at a steady rate in the coming years. The report provides a comprehensive review of the global market. Analysts have identified the key drivers and restraints in the overall market. The historical milestones achieved by the global market and emerging trends have also been studied in this report. Adopting such market research report is becoming very essential for the businesses as it supports with the better decision making, revenue generation, prioritizing market goals and profitable business.

The report is objective in nature but includes valuable comments by subject-matter experts. The Immunoassay Reagents and Devices Market research report authenticates and affirms the findings listed by the research analysts. The investigative approach of the research report allows the readers to get a detailed understanding of the finest nuances affecting the market dynamics. This report opens a discussion about the changing economy, governing policies, and political shifts that are expected to shape the market. Moreover, the report assists you in figuring out brand awareness, market landscape, possible future issues, industry trends and customer behaviour which ultimately leads to refined business strategies.

MAJOR TOC OF THE REPORT

Chapter One: Immunoassay Reagents and Devices Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three : Immunoassay Reagents and Devices Market Competition, by Players

Chapter Four: Global Immunoassay Reagents and Devices Market Market Size by Regions

Chapter Five: North Immunoassay Reagents and Devices Market by Countries

Chapter Six: Europe Immunoassay Reagents and Devices Market Revenue by Countries

Chapter Seven: Asia-Pacific Immunoassay Reagents and Devices Market Revenue by Countries

Chapter Eight: South Automotive Immunoassay Reagents and Devices Market Revenue by Countries

Chapter Nine: Middle East and Immunoassay Reagents and Devices Market Revenue Equipment by Countries

Chapter Ten: Global Immunoassay Reagents and Devices Market Segment by Type

Chapter Eleven: Global Immunoassay Reagents and Devices Market by Application

Get TOC Details: https://www.databridgemarketresearch.com/toc/?dbmr=global-immunoassay-reagents-and-devices-market

major companies dealing in the global immunoassay reagents and devices market report are F. Hoffmann-La Roche Ltd, Siemens, Randox Laboratories Ltd., Abbott, Bio-Rad Laboratories, Inc., Merck KGaA, Beckman Coulter, Inc. (a subsidiary of Danaher), Sysmex Corporation, bioMérieux SA, Thermo Fisher Scientific, Inc., BD, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., DiaSorin S.p.A, Ortho Clinical Diagnostics, QIAGEN, Quidel Corporation, BioCheck, Inc., Bio-Techne, PerkinElmer Inc., Agilent Technologies, Inc., Luminex Corporation, MESO SCALE DIAGNOSTICS, LLC among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Access Full Report https://www.databridgemarketresearch.com/reports/global-immunoassay-reagents-and-devices-market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

Browse Related Reports@

Medical Waste Management Market

Yeast Protein Expression Service Market

0 notes

healtcare · 3 years

Text

Global Haematology and Flow Cytometry Market

Global Haematology and Flow Cytometry Market is expected to reach $XX Mn by 2026 from $XX Mn in 2019, at a CAGR of 8.5% during forecast period.

Global Haematology and Flow Cytometry Market Overview:

Hematology is a medical specialty that deals with the study and treatment of blood. This is concerned with the diagnosis, study, treatment, and prevention of blood diseases. Flow cytometry is an analytical tool that is used in the measurement and analysis of several physical characteristics of cells or particles suspended in a fluid using a laser beam. The method helps to subclassify cell types to decide on the best treatment plan.

Global Haematology and Flow Cytometry Market Dynamics:

Rising global incidence and prevalence of chronic diseases like blood cancer is the major driving factor for the market growth. According to the National Cancer Institute in 2018, it was being estimated that 60,300 new leukemia cases are diagnosed and the deaths are around 24,470 cases in the United States. The increasing number of HIV cases globally is an important driver for the flow cytometry market. This is because the flow cytometry technique has its direct application in HIV diagnosis. According To UNAIDS in 2017, 31.1-43.9 million people globally are living with HIV by out of which 1.8 million are newly affected with HIV. Flow cytometry uses light scattering to determine the identity of cells. Increasing adoption of flow cytometry techniques in research and academia and growing initiatives in the field of immunology and Immuno-oncology researches are expected to propel the growth of the global flow cytometry market. Growth in stem cell research and the development of high-throughput flow cytometry technologies are likely to add new opportunities for this market in the coming years. Increasing regulatory approval and the introduction of technologically advanced flow cytometry solutions are expected to facilitate market growth over the forecast period. For instance, in June 2020, Sysmex Corporation launched the XF-1600 flow cytometer for laboratories, in North America. A significant restraint on the flow cytometry market is the availability of cheaper and better alternatives. ELISA (enzyme-linked immunosorbent assay) and radioimmunoassay are two of these alternatives. Although flow cytometry, ELISA, and radioimmunoassay are all methods for detecting "problem cells" in a community of cells, ELISA and radioimmunoassay are less expensive and easier to use. Along with this, the dearth of skilled technicians for managing such advanced technology is expected to restrain the market growth. The report has profiled twenty key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.

Global Haematology and Flow Cytometry Market Segment Analysis:

The Global Haematology and Flow Cytometry Market is segment on the basis of Product, Technology and End-Users. Based on Product, the flow cytometry instruments segment is expected to dominate the global market. The segment is further classified into cell analyzers and cell sorters. It held a market share of 25% in 2020. This high share is attributed to new advancements in technology and the introduction of novel cytometers by key players. The high price of these instruments is also contributing toward the high revenue generation in this segment. Along with this, reagents and consumables also held a prominent share in 2020. Owing to their increased adoption in diagnostics and research the segment is expected to register lucrative growth over the forecast period. The large share of this segment is mainly attributed to the growing research activities to develop and prove the efficacy of various assays and kits, and the commercialization of high-quality and application-specific consumables, reagents, and assays. Based on technology, the cell-based flow cytometry segment held the largest market share of 76% in 2020. The highest share is due to an increase in demand for early diagnosis and increased understanding of the related benefits of cell-based assays. In addition, advances in cell-based assay technology, such as innovations in tools, labels, affinity reagents, software, and algorithms, are expected to accelerate adoption in the coming years. To know about the Research Methodology :- Request Free Sample Report

Global Haematology and Flow Cytometry Market Regional Insights:

North America dominated the global market in 2020. The region dominated the global market in 2020 by holding a market share of 39.1%. This dominance is attributed due to the United States' high healthcare spending, well-developed healthcare system, and widespread adoption of technologically advanced flow cytometry solutions. In addition, the established pharmaceutical industry, as well as extensive research activities by research universities and pharmaceutical companies has generated huge demand for flow cytometry solutions for research universities and pharmaceutical companies have created a huge demand for flow cytometry solutions for research needs. APAC region is projected to exhibit highest CAGR during forecast period. This high growth can be attributed to the extensive growth in the pharmaceutical and biotechnology industries of emerging economies, such as China and India. The lucrative growth exhibited by this region is also an outcome of continuous government support for the establishment of the pharmaceutical industry in emerging countries. The report also helps in understanding Global Haematology and Flow Cytometrys Market dynamics, structure by analyzing the market segments and project the Global Haematology and Flow Cytometrys Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Haematology and Flow Cytometrys Market make the report investor’s guide.

Global Haematology and Flow Cytometry Market, key developments:

• In September 2018, the U.S. FDA awarded a grant of ~$18 million over a period of four years for 12 new clinical trials. These clinical trials are aimed at developing products for patients with rare diseases (including primary sclerosing cholangitis, stargardt disease, Cushing disease, acute myeloid leukemia, and graft versus host disease, among others). • In March 2017, Cytek Biosciences Inc., a manufacturer and supplier of flow cytometry products and services launched its DxP Athena flow cytometry system. The system is compact, powerful, easy-to-use cell analyzer that are typically only found in conventional instruments that come with a much higher price tag. The DxP Athena makes the benefits of flow cytometry which are more readily available to larger number of researchers by its compact size. • In 2016, the Global Clinical Trials Fund (U.K.) launched a dedicated fund with an upper limit of $662,185 to support clinical trials across the world related to the testing of new experimental drugs and existing drugs developed for dementia.

Global Haematology and Flow Cytometry Market Scope: Inquire before buying

Global Haematology and Flow Cytometry Market, by Region:

• North America • Europe • South America • MEA • APAC

Global Haematology and Flow Cytometry Market, Key players:

• Becton, Dickinson and Company • Beckman Coulter, Inc. • Bio-Rad Laboratories, Inc. • Thermo Fisher Scientific, Inc. • Merck KGaA • Sysmex Partec GmbH • Luminex Corporation • Miltenyi Biotec GmbH • Sony Biotechnology • Abbott • Agilent Technologies • CellaVision • Horiba • Nihon Kohden • Ortho-Clinical Diagnostics • Roche • Siemens Healthineers • Sysmex • Miltenyi Biotec • Apogee Flow Systems Ltd.

#Haematology #Flow Cytometry #Haematology and Flow Cytometry

0 notes

rdagade · 3 years

Text

Global Haematology and Flow Cytometry Market

is expected to reach $XX Mn by 2026 from $XX Mn in 2019, at a CAGR of 8.5% during forecast period.

Global Haematology and Flow Cytometry Market Overview:

Global Haematology and Flow Cytometry Market Dynamics:

Increasing adoption of flow cytometry techniques in research and academia and growing initiatives in the field of immunology and Immuno-oncology researches are expected to propel the growth of the global flow cytometry market. Growth in stem cell research and the development of high-throughput flow cytometry technologies are likely to add new opportunities for this market in the coming years. Increasing regulatory approval and the introduction of technologically advanced flow cytometry solutions are expected to facilitate market growth over the forecast period. For instance, in June 2020, Sysmex Corporation launched the XF-1600 flow cytometer for laboratories, in North America. A significant restraint on the flow cytometry market is the availability of cheaper and better alternatives.

ELISA (enzyme-linked immunosorbent assay) and radioimmunoassay are two of these alternatives. Although flow cytometry, ELISA, and radioimmunoassay are all methods for detecting "problem cells" in a community of cells, ELISA and radioimmunoassay are less expensive and easier to use. Along with this, the dearth of skilled technicians for managing such advanced technology is expected to restrain the market growth.

The report has profiled twenty key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.

Global Haematology and Flow Cytometry Market Segment Analysis:

Based on technology, the cell-based flow cytometry segment held the largest market share of 76% in 2020. The highest share is due to an increase in demand for early diagnosis and increased understanding of the related benefits of cell-based assays. In addition, advances in cell-based assay technology, such as innovations in tools, labels, affinity reagents, software, and algorithms, are expected to accelerate adoption in the coming years.

To know about the Research Methodology :-

Request Free Sample Report

Global Haematology and Flow Cytometry Market Regional Insights:

This high growth can be attributed to the extensive growth in the pharmaceutical and biotechnology industries of emerging economies, such as China and India. The lucrative growth exhibited by this region is also an outcome of continuous government support for the establishment of the pharmaceutical industry in emerging countries. The report also helps in understanding Global Haematology and Flow Cytometrys Market dynamics, structure by analyzing the market segments and project the Global Haematology and Flow Cytometrys Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Haematology and Flow Cytometrys Market make the report investor’s guide.

Global Haematology and Flow Cytometry Market, key developments:

For more information visit@ https://www.maximizemarketresearch.com/market-report/global-haematology-and-flow-cytometry-market/98749/

Global Haematology and Flow Cytometry Market Scope: Inquire before buying

Global Haematology and Flow Cytometry Market, by Region:

• North America • Europe • South America • MEA • APAC

Global Haematology and Flow Cytometry Market, Key players:

This report submitted by Maximize market Research Company

Customization of the report:

Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Lumawant Godage

Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: [email protected]

Address: Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk,Pune, Maharashtra 411051, India.

Contact: +919607195908

#Global Haematology and Flow Cytometry Market

0 notes

marketresearchlove-blog · 4 years

Text

Asia-Pacific Immunoassay Reagents and Devices Market

Asia-Pacific Immunoassay Reagents and Devices Market By Product (Reagents & Kits, Analyzers), Platform (Enzyme Immunoassay, Fluorescence Immunoassays, Chemiluminescence Immunoassays, Radioimmunoassays, Others), Technique (Enzyme-Linked Immunosorbent Assays, Enzyme-Linked Immunospot, Rapid Tests, Western Blotting, Immuno-PCR, Other), Specimen Type (Blood, Urine, Saliva, Others), Application (Oncology and Endocrinology, Hematology & Blood Screening, Cardiology, Infectious Diseases, Bone & Mineral Disorders, Autoimmune Disorders, Toxicology, Neonatal Screening, Other Applications), End User (Pharmaceutical And Biotechnology Companies, Clinical Laboratories, Hospitals, Research & Academic Laboratories, Blood Banks, Others), Countries (China, Japan, India, South Korea, Australia, Malaysia, Singapore, Thailand, Indonesia, Philippines and rest of Asia-Pacific),Market Trends and Forecast to 2027.

Request-a-sample@https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-immunoassay-reagents-and-devices-market

Market Analysis and Insights: Asia-Pacific Immunoassay Reagents and Devices Market

Asia-Pacific immunoassay reagents and devices market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a highest CAGR of 7.1% the forecast period of 2020 to 2027 and expected to reach USD 7,412.67 million by 2027. Rising geriatric population and increasing adoption immunoassay in emerging market is the factors for the market growth.

Immunoassay plays an important role in diagnosis of disease and also helps in drug discovery and hence used in many pharmaceutical as well as biotechnology industries. Rising geriatric population with number of diseases in Asia-Pacific is one of the major factors which is helping the market to grow. With the advancement in immunoassay devices, nowadays it is easy to diagnose diseases which lead the demand for the market. Increasing geriatric population in Asia can be driving factor for the growth for the market. Increasing geriatric population with high incidence of disease requires detection for further treatment. For instance, according to UNFPA, older persons aging over 60 in the Asia region will triple between 2010 and 2050 which is approximately to 1.3 billion people. Most of the aging population suffer from disease in which testing is required.

This immunoassay reagent and devices market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Asia-Pacific Aluminum Casting Market Size, Status and Forecast 2018 – 2025

· Asia-Pacific Aluminum Casting Market Overview

· Asia-Pacific Aluminum Casting Market Manufacturers Profiles

· Asia-Pacific Aluminum Casting Market Sales, Revenue, Market Share and Competition by Manufacturer

· Asia-Pacific Aluminum Casting Market Analysis by Regions

· Asia-Pacific Aluminum Casting Market by Countries

· Asia-Pacific Aluminum Casting Market Segment by Type

· Asia-Pacific Aluminum Casting Market Segment by Application

· Asia-Pacific Aluminum Casting MarketForecast

· Sales Channel, Distributors, Traders and Dealers

· Research Findings and Conclusion

· Appendixes

Get Detailed Toc @https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-immunoassay-reagents-and-devices-market

Asia-Pacific Immunoassay Reagents and Devices Market Scope and Market Size

Asia-Pacific immunoassay reagents and devices market is segmented on the basis of by product, platform, technique, specimen type, application, and end-user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

· On the basis of product, immunoassay reagents and devices market is segmented into reagents & kits and analyzers. In 2020, reagents & kits segment is exceeding the market due to extreme usage in disease detection and drug development. Increased diseases require proper diagnosis for further treatment. And hence, companies are developing number of kits and reagents and providing in market for further use. In November 2018, bioMérieux SA acquired the majority stake of Suzhou Hybiome Biomedical Engineering Co. Ltd. (China). The company developing in an immunoassay tests in a more advanced way to deliver high throughput analysis. This acquisition gives bioMérieux SA an opportunity to expand their product portfolio to making it even stronger diagnostic market in China.

· On the basis of platform, immunoassay reagents and devices market is segmented into chemiluminescence immunoassays, fluorescence immunoassays, enzyme immunoassays, radioimmunoassays, and others. In 2020, enzyme immunoassay segment is dominating the market because of its advantages such as ease in performing test, accurate result and many others. However, chemiluminescence immunoassays are growing due to its benefits in performing assays to get accurate result.

· On the basis of technique, immunoassay reagents and devices market is segmented into enzyme-linked immunosorbent assays, rapid tests, enzyme-linked immunospot, western blotting, immuno-PCR, and other techniques. Enzyme-linked immunosorbent assays segment is dominating because it is simple to perform, highly sensitive offer accurate result for any disease detection or in any drug development. It is one of the accurate techniques that provide better diagnosis in diseases.

· On the basis of specimen type, immunoassay reagents and devices market is segmented into saliva, urine, blood, and others. Blood is easy to detect and provides accurate estimation rate for a particular foreign particle.

· On the basis of application, immunoassay reagents and devices market is segmented into infectious diseases, oncology and endocrinology, bone & mineral disorders, cardiology, hematology & blood screening, autoimmune disorders, toxicology, neonatal screening, and other applications. Oncology and endocrinology segment is dominating because of high incidence rate worldwide which can be detected easily with the use of immunoassays. Along with the detection, various pharma companies are involved in developing drugs for the treatment of diseases. These diseases can be developed by using immunoassays. Cancer incidence is rapidly growing worldwide due to aging and growing population. For instance, according to WHO, 15.0% of the people worldwide has been registered with cancer in which Asia accounts for 6.5%.

· On the basis of end user, immunoassay reagents and devices market is segmented into hospitals, clinical laboratories, pharmaceutical and biotechnology companies, blood banks, research & academic laboratories, and others. Pharmaceutical and biotechnology segment is dominating the market as immunoassays are mostly utilized by these industries in performing various assay development for drugs, vaccines and many others.

Competitive Landscape and Immunoassay Reagents and Devices Market Share Analysis

Asia-Pacific immunoassay reagents and devices device market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Asia-Pacific presence, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, concept cars, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Asia-Pacific immunoassay reagents and devices market.

The major players covered in the report are F. Hoffmann-La Roche Ltd, Abbott, Bio-Rad Laboratories, Inc., Merck KGaA, Siemens, Randox Laboratories Ltd., Beckman Coulter, Inc (a subsidiary of Danaher), Sysmex Corporation, bioMérieux SA, Thermo Fisher Scientific, Inc, BD, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., DiaSorin S.p.A., Ortho Clinical Diagnostics (a subsidiary of Carlyle Investment Management L.L.C), QIAGEN, Quidel Corporation, BioCheck, Inc., Bio-Techne, PerkinElmer Inc, Agilent Technologies, Inc, Luminex Corporation, MESO SCALE DIAGNOSTICS, LLC and others. Immunoassay reagents and devices market share data is available for Asia-Pacific. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately

Many joint ventures and developments are also initiated by the companies worldwide which are also accelerating the Asia-Pacific immunoassay reagents and devices Market.

For instance,

· In November 2018, Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China) has launched an immunoassay system called as Mindray CL-900i Chemiluminescence Immunoassay System with advanced technology. This system provides quality immunoassay testing. The company has increased its product portfolio that has helped in maximizing the customer base around the world. Partnership, expansion and other strategies enhances the company market share with increased coverage and presence. It also provides the benefit for organisation to improve their offering for immunoassay reagent and devices market products for the welfare of the patients.

Speak-to-analyst@https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=asia-pacific-immunoassay-reagents-and-devices-market

Customization Available : Asia-Pacific Immunoassay Reagents and Devices Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), product under development data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.

Buy Now @https://www.databridgemarketresearch.com/checkout/buy/enterprise/asia-pacific-immunoassay-reagents-and-devices-market

About Us:

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

RELATED REPORTS

· Global Immunoassay Reagents and Devices Market – Industry Trends and Forecast to 2027

· North America Immunoassay Reagents and Devices Market – Industry Trends and Forecast to 2027

· Europe Immunoassay Reagents and Devices Market – Industry Trends and Forecast to 2027

#Asia-Pacific Immunoassay Reagents and Devices Market #Asia-Pacific Immunoassay Reagents and Devices Marketforcast

0 notes

researchtrendingnews · 4 years

Text

Blood Screening Market Strategic Insights and key Business Influencing Factors | Major Players – Thermo Fisher Scientific Inc. , BioMérieux SA , Beckman Coulter, Inc. , Abbott , F. Hoffmann-La Roche Ltd.

Blood Screening Market Screening process can also be called as the first line of defense in health care field providing a safe blood supply and helping in minimizing the problems associated with transfusion-transmitted infection. Government associations from every country should establish blood donor programs to provide information and education about blood donations. Various techniques are available in the market to perform assays for detection of the problems related to health is Immunoassays (IAs) and Nucleic Acid Amplification Technology (NAT) assays. Immunoassay is categorized into enzyme immunoassays (EIAs), chemiluminescent immunoassays (CLIAs), haemagglutination (HA)/particle agglutination (PA) assays andsimple single-use assays (rapid tests).

Asia Pacific blood screening market is expected to register a healthy CAGR of 10.5% in the forecast period of 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Get Sample Report at :

https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-blood-screening-market

Competitive Analysis: Asia-Pacific Blood Screening Market

Some of the prominent participants operating in this market are Enzo Biochem Inc., Meridian Bioscience, Inc, BD , Bio-Rad Laboratories, Inc. , Thermo Fisher Scientific Inc. , BioMérieux SA , Beckman Coulter, Inc. , Abbott , F. Hoffmann-La Roche Ltd (Switzerland), Cepheid , GRIFOLS INTERNATIONAL, S.A. , Siemens AG , Ortho Clinical Diagnostics , Immucor, Inc., Hologic Inc. , among others.

High Temperature Elastomer Market Size, Status and Forecast 2026

Market Overview

Manufacturers Profiles

Blood Screening Sales, Revenue, Market Share and Competition by Manufacturer

Blood Screening Market Analysis by Regions

North America Blood Screening by Countries

Europe Blood Screening by Countries

Asia-Pacific Blood Screening by Countries

South America Blood Screening by Countries

Middle East and Africa Blood Screening by Countries

Blood Screening Market Segment by Type

Blood Screening Market Segment by Application

Blood Screening Market Forecast

Sales Channel, Distributors, Traders and Dealers

Research Findings and Conclusion

Appendixes

Get Detailed TOC:

https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-blood-screening-market

Scope of the Blood Screening Market

Asia Pacific Blood Screening Market, By Products & Services (Reagents & Kits, Instruments, Software & Services), Technology (Enzyme-Linked Immunosorbent Assay, Rapid Tests, Next-Generation Sequencing, Nucleic Acid Test, Western Blot Assay, Others), Disease Type (Oncology, Diabetes Mellitus, Cold & Flu, Cholesterol, Infectious Diseases, Respiratory Diseases, HIV/AIDS, Others), End User (Diagnostic Centers, Blood Bank, Hospitals, Clinics, Ambulatory Surgical Centers), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa)- Industry Trends and Forecast to 2025

Screening process can also be called as the first line of defense in health care field providing a safe blood supply and helping in minimizing the problems associated with transfusion-transmitted infection. Government associations from every country should establish blood donor programs to provide information and education about blood donations. Various techniques are available in the market to perform assays for detection of the problems related to health is Immunoassays (IAs) and Nucleic Acid Amplification Technology (NAT) assays. Immunoassay is categorized into enzyme immunoassays (EIAs), chemiluminescent immunoassays (CLIAs), haemagglutination (HA)/particle agglutination (PA) assays andsimple single-use assays (rapid tests).

Market Segmentation: Asia-Pacific Blood Screening Market

Global Blood Screening Market is segmented into reagents & kits, instruments and software & services. Reagents & kits are further sub segmented into NAT reagents & kits, ELISA reagents & kits and others reagents. NAT reagents is further sub segmented into enzymes and polymerases, standards and controls, probes and primers, buffers, nucleotides and solutions also labeling and detection reagents. ELISA reagents & kits are further sub segmented into immunosorbents, controls, conjugates (antigen or antibody-conjugated enzyme), substrates (of enzymes) and sample diluents and wash solutions. Instruments segment are further segmented into instruments, product type and instruments, purchase type. In 2017, reagents & kits segment is expected to dominate the global blood screening market with 49.1% market share and is expected to grow at the CAGR of 9.4% in the forecast period 2018 to 2025. However, instruments segment is expected to grow at the highest CAGR of 10.2% in the forecast period,

In January 2017, F. Hoffmann-La Roche Ltd (Switzerland) launched haematology testing solution. This solution is called the cobas m 511 integrated haematology analyser. This launch marked the entry for Roche Diagnostics in the haematology market.

On the basis of disease type, the market is segmented into respiratory diseases, diabetes mellitus, oncology, cholesterol, HIV/AIDS, cold & flu, infectious diseases and others. In 2017, oncology segment is expected to dominate the global blood screening market with 24.9% market sharegrowing at the highest CAGR of 10.3% in the forecast period 2018 to 2025.

In June 2018, Thermo Fisher Scientific (U.S.) launched Oncomine TCR Beta-SR Assay. It is a new next-generation sequencing (NGS) solution in the field of immuno-oncology research. This helped company to expand their business by enhancing their product portfolio.

On the basis of end user the market is segmented into hospitals, clinics, diagnostic centers, blood bank and ambulatory surgical cenetrs. In 2017, diagnostic centers segment is expected to dominate the global blood screening market with 28.8% market share, growing at the highest CAGR of 10.4%in the forecast period 2018 to 2025.

In September 2016, Siemens Healthineers (Germany) acquired Conworx Technology GmbH (Germany) for point-of-care device interfaces and data management solutions. The company’s products and solutions designed helped in increasing efficiency and to reduce costs.

Reasons to Purchase this Report:

The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.

Regions/Countries that are expected to witness the fastest growth rates during the forecast period.

The latest developments, market shares, and strategies that are employed by the major market players.

Speak to Author :

https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=asia-pacific-blood-screening-market

Key insights in the report:

Complete and distinct analysis of the market drivers and restraints

Key Market players involved in this industry

Detailed analysis of the Market Segmentation

Competitive analysis of the key players involved

About Us:

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

#Blood Screening Market #Blood Screening Market share #Blood Screening Market size #Blood Screening Market trends #Blood Screening Market report #Blood Screening Market news #Blood Screening Market research #Blood Screening Market overview

0 notes

marketresearch-articles · 3 years

Text

Immunoassay Reagents and Devices Market Share by 2028: Upcoming Trends and Analysis

Immunoassay Reagents and Devices Market is grow at a CAGR 4.9%in the forecast 2021 to 2028.

Immunoassay Reagents and Devices Market Scope and Size

Get the sample copy of Report here https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-immunoassay-reagents-and-devices-market

Global Immunoassay Reagents and Devices Market Country Level Analysis

Competitive Landscape and Immunoassay Reagents and Devices Market Share Analysis

The immunoassay reagents and devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to global immunoassay reagents and devices market.

MAJOR TOC OF THE REPORT

Chapter One: Immunoassay Reagents and Devices Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three : Immunoassay Reagents and Devices Market Competition, by Players

Chapter Four: Global Immunoassay Reagents and Devices Market Size by Regions

Chapter Five: North Immunoassay Reagents and Devices Market by Countries

Chapter Six: Europe Immunoassay Reagents and Devices Market Revenue by Countries

Chapter Seven: Asia-Pacific Immunoassay Reagents and Devices Market Revenue by Countries

Chapter Eight: South America Immunoassay Reagents and Devices Market Revenue by Countries

Chapter Nine: Middle East and Immunoassay Reagents and Devices Market Revenue Equipment by Countries

Chapter Ten: Global Immunoassay Reagents and Devices Market Segment by Type

Chapter Eleven: Global Immunoassay Reagents and Devices Market Segment by Application

Get TOC Details: https://www.databridgemarketresearch.com/toc/?dbmr=global-immunoassay-reagents-and-devices-market

The major companies dealing in the global immunoassay reagents and devices market report are F. Hoffmann-La Roche Ltd, Siemens, Randox Laboratories Ltd., Abbott, Bio-Rad Laboratories, Inc., Merck KGaA, Beckman Coulter, Inc. (a subsidiary of Danaher), Sysmex Corporation, bioMérieux SA, Thermo Fisher Scientific, Inc., BD, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., DiaSorin S.p.A, Ortho Clinical Diagnostics, QIAGEN, Quidel Corporation, BioCheck, Inc., Bio-Techne, PerkinElmer Inc., Agilent Technologies, Inc., Luminex Corporation, MESO SCALE DIAGNOSTICS, LLC among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Access Full Report https://www.databridgemarketresearch.com/reports/global-immunoassay-reagents-and-devices-market

About Us:

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

Browse Related Reports@

Veterinary Lasers Market

Yeast Protein Expression Service Market

0 notes

captainmariawilliams-blog · 5 years

Text

Global Immuno Oncology Assays Kit Market 2019 Innovative Trends and Insights Research upto 2024

Research study on Global Immuno Oncology Assays Kit Market - Examination of Market Segmentation Including Product Type, Application, And Regions

Global Immuno Oncology Assays Kit Market Growth 2019-2024 delivers compilation for the market, which primarily focuses on the market trends, demand spectrum, and prospects of this industry over the forecast period from 2019 to 2024. The report comprises wide-ranging information about the market overview, top vendors, key market highlights, product types, market drivers, challenges, trends, Immuno Oncology Assays Kit industry landscape, size and forecast, five forces analysis, key leading countries/region. The report passes on a sketch-view of the market base and extensions, and statistical overview in terms of trends outlining the geographical opportunities and contributions by prominent industry share contenders. In short, the report evidently illustrates its encouraging or obtrusive points for global and regional growth.

DOWNLOAD FREE SAMPLE REPORT: https://www.fiormarkets.com/report/global-immuno-oncology-assays-kit-market-growth-2019-2024-380008.html#sample

Brief of The Market Segmentation:

As per the product type, the Immuno Oncology Assays Kit market is categorized and the market share of each product along with the project valuation is mentioned in the report. The report consists of facts related to every single product's sale price, revenue, growth rate over the estimation period. According to the application spectrum, the market is categorized and the data pertaining the market share of each product application as well as estimated revenue that each application registers for is mentioned in the report.

Market share of global Immuno Oncology Assays Kit industry is dominated by companies like , Thermo Fischer Scientific, Roche Diagnostics, Agilent Technologies, Illumina and others which are profiled in this report as well in terms of sales, price, revenue, gross margin and market share.

As per the report, in terms of provincial scope, the market is divided into Americas (United States, Canada, Mexico, Brazil), APAC (China, Japan, Korea, Southeast Asia, India, Australia), Europe (Germany, France, UK, Italy, Russia, Spain), Middle East & Africa (Egypt, South Africa, Israel, Turkey, GCC Countries) the product's usage throughout the geographical landscape.

READ FULL REPORT: https://www.fiormarkets.com/report/global-immuno-oncology-assays-kit-market-growth-2019-2024-380008.html

Specifics Are Given In The Report:

The study delivers a detailed evaluation of drivers which may influence the profit scale of this industry positively.

The estimated remuneration of the application segments delivered in the report

Revenue estimation of each product segment

Market share which every application segment may hold over the projected period

Consumption market share impacting every application type

The study also gives information pertaining to the elaborate number of challenges that may constrain the Immuno Oncology Assays Kit market expansion.

The anticipated surge in consumption rates over the projected years, spanning the geographies listed

The report reveals that product launches have been an essential strategy adopted by the industry players in the Immuno Oncology Assays Kit market. To stay ahead in the competition, the market leaders are using competitive advancements such as joint ventures, strategic association, collaboration and acquisitions, new product development, and research. Market vital features covered in this report include revenue, capacity application rate, expenditures, manufacturing, price, gross, growth ratio, supply, industry demand, export, and import study, and CAGR up to 2024.

Customization of the Report: This report can be customized to meet the client’s requirements. Please connect with our sales team ([email protected]), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements

#Global Immuno Oncology Assays Kit Market 2019 Global Immuno Oncology Assays Kit Market Trends Global Immuno Oncology Assays Kit Market Analy

0 notes

kraftresearch2019 · 5 years

Text

Immuno Oncology Assays Market 2019 SWOT Analysis by Players: Thermo Fischer Scientific, Roche Diagnostics, Agilent Technologies

Research on the 2019-2025 Global Immuno Oncology Assays market provides a basic overview of the industry including concepts, classifications, applications and the structure of the supply chain. Market analysis for the international markets is provided by Global Immuno Oncology Assays, including developments in growth, competitive landscape analysis, and key regions development status. Immuno Oncology Assays industry Policy and plans for development are discussed as well as processes for manufacturing and cost structures are also analyzed. The Immuno Oncology Assays also provides information on import/export use, supply and demand estimates, cost, price, revenue, and gross margins.

For In-depth Information Get Free Sample Copy of this Report@ https://www.researchkraft.com/request-sample/956722

The Immuno Oncology Assays report provides an in-depth analysis of different market players, their markets and services. It also helps to understand industry strategies such as alliances, agreements, mergers & acquisitions, and the introduction of new products introduced by key players in the Immuno Oncology Assays. To understand the factors leading to Immuno Oncology Assays market fluctuations, the study is a valuable source of information for investors, industry researchers, enterprise-level organizations, and business experts.

Global Immuno Oncology Assays market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the TOP PLAYERS including;

Thermo Fischer Scientific, Roche Diagnostics, Agilent Technologies, Illumina

Breakdown Data by Type

Immunoassay

Flow Cytometry

Next Generation Sequencing

Breakdown Data by Application

Research

Clinical Diagnostics

Global Immuno Oncology Assays Market Geographic Scope:

North America (U.S., Canada, Mexico) Europe (Germany, U.K., France, Italy, Russia, Spain, etc.) Asia-Pacific (China, India, Japan, Southeast Asia, etc.) South America (Brazil, Argentina, etc.) Middle East & Africa (South Africa, Saudi Arabia, etc.)

Click here to get discount@ https://www.researchkraft.com/check-discount/956722

The report on the market for Immuno Oncology Assays deeply analyzes important features in major developing markets. The Immuno Oncology Assays study involves the size of the market, the latest trends, drivers, risks, opportunities and main segments of the market. The research reveals market dynamics for the current market environment and future scenario over the forecast period in several geographic segments along with Immuno Oncology Assays market analysis. In addition to a SWOT analysis of key vendors, the Immuno Oncology Assays report also includes a comprehensive market and vendor landscape. It also talks about the size of the Immuno Oncology Assays market and the growth aspects of different segments.

The global Immuno Oncology Assays Industry provides an overview of recent growth factors in the global market. Recent innovations have created multiple growth opportunities for both prevailing firms and new market entrants, according to the report. Global Immuno Oncology Assays Market Research Reports provide market trends, competitive landscape, market analysis, cost structure, capacity, revenue, gross profit, distribution and forecast 2025.

Key Takeaways From This Report:

Discover Immuno Oncology Assays market potential by analyzing product design, end-use applications growth rates, cost, and size.

Understand the different dynamics that affect the market for Immuno Oncology Assays – business opportunities, key driving forces, and challenges.

To analyze the global key players, SWOT analysis, value, and global Immuno Oncology Assays market share for top players.

The Immuno Oncology Assays market report estimates the sales and distribution channels across key geographies to boost top-line revenues.

To evaluate each submarket strategically with regard to individual growth trend and Immuno Oncology Assays market contribution

Assess the supply-demand gaps, import-export figures, and the Immuno Oncology Assays industry's restrictive landscape for the world's leading countries.

To evaluate Immuno Oncology Assays industry trends such as extensions, deals, releases of new products and business acquisitions.

For More Information On This Report, Please Visit @ https://www.researchkraft.com/send-an-enquiry/956722

#Immuno Oncology Assays Market

0 notes

healthy-insights · 7 years

Text

CA Tumor Markers Testing Market Research Report: Forecast up to 2023

CA Tumor Markers Testing Market: Overview

Tumor markers are biological substances found in the body tissues, blood and urine; that can be elevated when a person is suffering from cancer. Tumor markers are normally made of cancerous cells or by the body in response to cancer. Traditional tumor markers are proteins; however newer tumor markers are genetic substances. There are various types of cancer antigen (CA) tumor markers each indicative of a specific disease mechanism; and these tumors are used in oncology to help in the detection of cancer of a particular organ or site. An elevated level of a CA tumor marker can signify various forms of cancer such as breast cancer, colorectal cancer and ovarian cancer. Currently, the CA tumor marker testing market is a lucrative thanks to the high numbers of patients opting for such testing and the increasing base of cancer patients, which makes this industry not only highly profitable but also attractive to investors.

Some of the technologies used for the detection of CA tumor markers are as follows:

Radioimmunoassay (RIA)

Enzyme Immunoassays (EIA)

PCR

Latex Agglutination

Immuno-PCR

Nucleic acid sequence based amplification (NASBA)

Some of the types of cancer antigen marker usually used for cancer tumor testing are as follows:

Cancer Antigen 125 (CA 125), used for detecting epithelial ovarian cancer

Cancer Antigen 27-29 (CA 27-29), used for detecting breast cancer

Cancer Antigen 19-9 (CA 19-9), used for detecting colorectal cancer

Cancer Antigen 15-3 (CA 15-3), used for detecting breast cancer

View Report-

http://www.transparencymarketresearch.com/ca-tumor-markers-testing-market.html

CA Tumor Markers Testing Market: Regional Overview

From the geographical perspective, North America stands as the largest market for CA tumor markers testing owing to the large base of cancer patients. According to the American Cancer Society, approximately 1,660, 290 new cases of cancer were diagnosed in 2013. Another report published by the WHO, it was estimated that globally 14.1 million new cases of cancer were diagnosed and almost 8.2 million deaths related to cancer occurred in 2012.

However, other regional markets such as Southeast Asia, the Middle East, and Latin America are projected to be the potential markets in the near future. This can be ascribed to the increasing levels of disposable income among the population and the high rate of adoption of advanced cancer screening tools. It is expected that these emerging regions will be high-potential markets in the near future.

CA Tumor Markers Testing Market: Drivers

The overall CA tumor marker testing market is witnessing a remarkable growth owing to the increasing rate of incidence of cancer and other non-communicable disorders. Moreover, increasing geriatric population will further fuel the growing demand for tumor assays and novel cancer therapeutics globally. Moreover, trends show that the global CA tumor marker testing market could potentially be a lucrative field showing continued expansion owing to the spiraling adoption rate of diagnostic services and technologies that are more advanced than the previous ones.

With technological breakthroughs on the cards, projections show that this market will generate abundant opportunities for detecting targeted tumors, monitoring cellular response and for determining genetic predisposition. Furthermore, increased focus on retaining superior quality of life is some of the factors contributing in the growth of this market. However, a rise in the overall healthcare spending, rigid and, in some cases, unfavorable, reimbursement policies, and the high cost of developing new technologies are some of the factors that might act in the opposite direction of the growth of the CA tumor marker testing market.

CA Tumor Markers Testing Market: Competitive Dynamics

The global CA tumor markers testing market is observed as being a highly fragmented one because of the active participation of many players both established and emerging. The major players involved with the CA tumor markers testing market are Abbott Laboratories, Becton, Dickinson and Company, Applied Genetic Technologies Corporation, bioMérieux SA, Cepheid, Correlogic Systems, Inc., Myriad Genetics, Panacea Pharmaceuticals, Qiagen, Radient Pharmaceuticals, Siemens Healthcare, Targeted Diagnostics & Therapeutics and Thermo Fisher Scientific.

Request a brochure of this report to know what opportunities will emerge in the rapidly evolving CA Tumor Markers Testing Market during 2016- 2023

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11600

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: [email protected]

Website: http://www.transparencymarketresearch.com

0 notes

healthy-insights · 7 years

Text

CA Tumor Markers Testing Market Research Report: Forecast up to 2023

CA Tumor Markers Testing Market: Overview

Some of the technologies used for the detection of CA tumor markers are as follows:

Radioimmunoassay (RIA)

Enzyme Immunoassays (EIA)

PCR

Latex Agglutination

Immuno-PCR

Nucleic acid sequence based amplification (NASBA)

Some of the types of cancer antigen marker usually used for cancer tumor testing are as follows:

Cancer Antigen 125 (CA 125), used for detecting epithelial ovarian cancer

Cancer Antigen 27-29 (CA 27-29), used for detecting breast cancer

Cancer Antigen 19-9 (CA 19-9), used for detecting colorectal cancer

Cancer Antigen 15-3 (CA 15-3), used for detecting breast cancer

View Report-

http://www.transparencymarketresearch.com/ca-tumor-markers-testing-market.html

CA Tumor Markers Testing Market: Regional Overview

CA Tumor Markers Testing Market: Drivers

CA Tumor Markers Testing Market: Competitive Dynamics

Request a brochure of this report to know what opportunities will emerge in the rapidly evolving CA Tumor Markers Testing Market during 2016- 2023

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11600

About Us

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: [email protected]

Website: http://www.transparencymarketresearch.com

0 notes

healthy-insights · 7 years

Text

Immunoassay Market Research Report and Forecast 2016 - 2026

Immunoassays refer to chemical tests and diagnostic techniques used to measure the concentration of macromolecules i.e. proteins in a solution with the help of an antibody or immunoglobulin. Macromolecules include analytes or proteins and these analytical methods operate on the formation of antigen-antibody complexes resultant of specific immuno reactions. Immunoassay techniques are particularly suitable for the effective analysis of compounds in low volumes, especially in nanogram and picogram concentrations. Their high sensitivity, reliability, and applicability to various range of compounds, distinctive selectivity, and detection abilities at extreme low concentrations make immunoassays a powerful tool used for complex biological fluids such as blood, plasma, or urine. These tests are extensively employed in the clinical, environmental, and pharmaceutical fields. Presently, various immunoassay instruments are available commercially including ARCHITECT ci4100, ci8200, ci16200 (Abbott Diagnostics), VIDAS Immunoassay Analyzer (bioMerieux) Immunoassay System, UniCel DxC 660i Synchron Access Clinical System (Beckman Coulter), Clinical Diagnostics Group, and EVOLIS (Bio-Rad Laboratories).

Get Sample Copy of this Report @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19703

Immunoassays are performed in two different formats: homogenous or non-separation and heterogeneous or separation. Homogeneous immunoassays are executed by mixing the sample and reagents, followed by analysis; while heterogeneous assays, also known as multi-step assays, may run in multiple parts by adding and washing away the reagents at different levels during an experiment. With technological advancements leading to the development of new products, the immunoassay market is anticipated to observe incredible growth in the next few years.

Major drivers of the market are the consistent and aggressive investments in research and development by market players, rising focus on developing strong technological platforms for immunoassays, and the extensive application areas of immunoassays such as infectious diseases, cancer, and cardiac disorders. Additionally, the introduction of innovative software tools followed by the need for hospitals and laboratories to reduce service and maintenance costs further boost the demand for these analytical tests in the market. However, lack of access to and awareness about the instruments and techniques involved as well as their high cost may hamper its development of this market.

The global immunoassay instrument market can be segmented by application into the oncology, endocrinology, infectious disease testing, hematology, therapeutic drug monitoring, cardiology, and orthopedic sectors, of which infectious disease testing is expected to be dominant due to their wide prevalence. On the basis of product and technology, the market can be classified into the following categories: chemiluminescence (CLI) analyzers, enzyme linked immunosorbent assay (ELISA), immuno fluorescence analyzers (IFA), enzyme immunoassay instruments, and radioimmunoassay (RIA) analyzers multiplexed assay systems. End-users of the product include academic and research institutes, diagnostic laboratories, and hospitals, of which diagnostic laboratories are likely to lead the market.

View Report @ http://www.transparencymarketresearch.com/immunoassay-market.html

Geographically, the immunoassay market is distributed over North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America, followed by Europe, hold a major share in the immunoassay market due to the technological advancement, the subsequent accessibility and adoption of urbane diagnostic technology including immunoassays, and the presence of prominent instrument manufacturers in these regions. Asia Pacific exhibits growth at an adequate pace due to the economic conditions, rising disposable incomes improving the accessibility of health care services, increasing demand for immune assay kits, and the surge in geriatric population suffering from diseases such as cancer, blood related disorders, and infectious diseases.

Key players competing in this market are Abbott Laboratories, Beckman Coulter, Inc., and bioMerieux S.A, DiaSorin, EMD Millipore Corporation, Siemens Healthcare, Invitrogen (Life Technologies Corporation & Thermo Fisher Scientific), and Ortho-clinical Diagnostics.

About Us

US Office Contact

90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: [email protected] Website: http://www.transparencymarketresearch.com

0 notes

healthy-insights · 7 years

Text

Immunoassay Market: Technologies, Markets and Players

Download The Full Brouchre of Report http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19703

Browse Global Strategic Business Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19703

About Us Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge. Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement. US Office Contact 90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: [email protected] Website: www.transparencymarketresearch.com

0 notes

healthy-insights · 8 years

Text

Immunoassay Market Research Report by Current & Upcoming Trends Analysis 2026

Browse full report on Immunoassay Market -

http://www.transparencymarketresearch.com/immunoassay-market.html

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

Market segments and sub-segments

Market trends and dynamics

Supply and demand

Market size

Current trends/opportunities/challenges

Competitive landscape

Technological breakthroughs

Value chain and stakeholder analysis

The regional analysis covers:

North America (U.S. and Canada)

Latin America (Mexico, Brazil, Peru, Chile, and others)

Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)

Eastern Europe (Poland and Russia)

Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)

Middle East and Africa (GCC, Southern Africa, and North Africa)

Request for brochure of this report -

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19703

About Us

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: [email protected]

Website: http://www.transparencymarketresearch.com

0 notes

healthy-insights · 8 years

Text

Immunoassay Market Research Report by Current & Upcoming Trends Analysis 2026

Browse full report on Immunoassay Market -

http://www.transparencymarketresearch.com/immunoassay-market.html

The study is a source of reliable data on:

Market segments and sub-segments

Market trends and dynamics

Supply and demand

Market size

Current trends/opportunities/challenges

Competitive landscape

Technological breakthroughs

Value chain and stakeholder analysis

The regional analysis covers:

North America (U.S. and Canada)

Latin America (Mexico, Brazil, Peru, Chile, and others)

Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)

Eastern Europe (Poland and Russia)

Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)

Middle East and Africa (GCC, Southern Africa, and North Africa)

Request for brochure of this report -

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19703

About Us

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: [email protected]

Website: http://www.transparencymarketresearch.com

0 notes

healthy-insights · 8 years

Text

CA Tumor Markers Testing Market Research Report by Regional Analysis : forecast 2023

CA Tumor Markers Testing Market: Overview

Some of the technologies used for the detection of CA tumor markers are as follows:

Radioimmunoassay (RIA)

Enzyme Immunoassays (EIA)

PCR

Latex Agglutination

Immuno-PCR

Nucleic acid sequence based amplification (NASBA)

Some of the types of cancer antigen marker usually used for cancer tumor testing are as follows:

Cancer Antigen 125 (CA 125), used for detecting epithelial ovarian cancer

Cancer Antigen 27-29 (CA 27-29), used for detecting breast cancer

Cancer Antigen 19-9 (CA 19-9), used for detecting colorectal cancer

Cancer Antigen 15-3 (CA 15-3), used for detecting breast cancer

Browse full report on CA Tumor Markers Testing Market -

http://www.transparencymarketresearch.com/ca-tumor-markers-testing-market.html

CA Tumor Markers Testing Market: Regional Overview

CA Tumor Markers Testing Market: Drivers

CA Tumor Markers Testing Market: Competitive Dynamics

Request for brochure of this report -

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11600

About Us

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: [email protected]

Website: http://www.transparencymarketresearch.com

0 notes